IntelliAM AI Share Discussion Threads

[jotoha1] 12/10/2006 15:44

Still here and smiling for obvious reasons!!!

[james t kirk] 12/10/2006 15:00

Well done Martin, I became very wary with the online limit to sell at 1k for so long. I knew sooner or later it would have it's day in the sun, and as is typical I missed the boat. Where's that doom merchant Jotoha? I've noticed him spouting doom and gloom on other aim threads.

[martincoops] 12/10/2006 14:11

Thanks James I have been buying in on the way down so not much further to go now and I will start to make a profit :))

[james t kirk] 12/10/2006 14:03

Hey Martin, it's just back to the level I sold out at. I must admit I was tempted to buy back at 3.25p but didn't but I'm glad for you that at least it's recovered slightly.

The online bid is 75k now, which I haven't seen for a long time, I just hope the interest doesn't wain.

[martincoops] 12/10/2006 13:20

No.1 on the leader board now

Looking much better, good luck all

[james t kirk] 12/10/2006 09:54

No.2 on the leaders board!

[stemis] 12/10/2006 08:53

but it was the forecast by Corporate Synergy, house broker, of pre-tax profits this year of £1.05 million on turnover of £11.6 million that drew interest. The broker says that IMD is trading on a forward earnings multiple of 8.8 times for 2007, against 12.2 times for its peers.

P/E can only be 8.8 if there is no tax on PBT of £1.05M, so to compare it with its fully taxed peers is comparing apples and pears. Usual rubbish from Corporate Synergy.

[martincoops] 12/10/2006 07:48

Adds a bit more than the interims with regards to Clip-on

[martincoops] 12/10/2006 06:08

Smaller stock to watch


The AIM-listed International Medical Devices, which plans to consolidate the smaller end of the British medical devices sector, put on 3/8p to 3 5/8p on reassuring full-year results. IMD, which bought three companies during the year, reported sales of £3.8 million, but it was the forecast by Corporate Synergy, house broker, of pre-tax profits this year of £1.05 million on turnover of £11.6 million that drew interest. The broker says that IMD is trading on a forward earnings multiple of 8.8 times for 2007, against 12.2 times for its peers.

[james t kirk] 11/10/2006 16:31

Presumably some delayed buys will start to show soon, after an impressive late surge.

[james t kirk] 11/10/2006 08:34

Market sentiment is clearly not with this company and perhaps there's a trust factor with Mr Thomas? Seems a shame but I'm glad no longer to be holding.

[martincoops] 11/10/2006 08:02

I agree James but as I am in no rush to sell I am happy to wait.

[james t kirk] 11/10/2006 08:00

Martin, in normal circumstances I'd say this company is hugely undervalued, but the problem is the illiquidity of the stock. If you buy the shares you're lumped with them as they are ery difficult to sell.

One day this company will jump 100% in a day to get back to a realistic value.

[martincoops] 11/10/2006 07:54

Not a cop out James

EMS have to get the manufacturing premises in S Africa up and running as I dont think the 5million needles will last that long so they will be dependant on them for that.

Clip-on to be launched by December now that does sound good.

Interesting that the DHL will make it easier for INT to market and sell their products.

All in all a very informative RNS now lets see them build the business up and the share price will follow

[ladyfarmer] 11/10/2006 07:50

In my view they have achieved what they set out to do and I like this business model, with acquirees' management being incentivised to perform going forward and the acquisition cost largely dependent on performance. Time will tell but I see this as a good punt, getting in on the ground floor

[james t kirk] 11/10/2006 07:42

I've never seen quite so much padding in an RNS. It's hard to tell if the results are good with so much general information about their market.

I'm slightly wary about the final comment about how they are reliant on partners to help increase business, which is a bit of a cop out.

In theory they will be profitable this year to the tune of £950k, but that's if everything stays on track and they haven't stated how the new year has started.

On a positive note these results are out very quickly, considering year end was less than two months ago.

[ladyfarmer] 10/10/2006 16:00

Prelims are due to be announced tomorrow. I think they should be good news and will revalue upwards.

[jotoha1] 07/10/2006 14:04

Oh no , not another drop!! maybe Thomas is sticking out for 1/2p!

[james t kirk] 05/10/2006 08:34

Buying at 3.5p now..

[jotoha1] 04/10/2006 18:17

lady farmer, dont be silly , no institution would touch this stock!!!!!!!!!

[jotoha1] 04/10/2006 18:16

Oh dear me Martin, this has a familiar feel to it, maybe Thomas has put a buy order in, first time ever if he has, crooks the lot of them!!!

[ladyfarmer] 04/10/2006 09:59

There must be something orrible in the wings - eg a major sale by an institutional holder

[james t kirk] 04/10/2006 09:55

Well I'm glad I bailed out when I had the chance after the trading statement. Sadly this company's shares are so illiquid it's amazing what happens with one tiny sell.

[martincoops] 16/9/2006 19:23

Our "Clip-on" safe needle is completing its sterilisation tests for the CE
marking process and it is hoped that a launch of the product will take place by
December.

[martincoops] 16/9/2006 19:21

Jot

you dont know much do you, they have'nt even owned the companies for a year so how can they include full year sales! I think we all know that a company when buying and intergrating into eachother incurr costs. The fact that it is only a small loss shows that they have been prudent and invested wisely.

Before you comment on a share it is good practice to do some research, no wonder you lost money on FAR. Oh and here are some other points you missed in the announcment

* Integration of Meddis' logistics and administration successfully
completed and will yield material savings

* All 3 Group divisions traded to plan during the summer period

* Growth through acquisition to continue

* New product launches expected Q4